SkyePharma mulls 30% cuts at Lyon Geomatrix plant
UK drugmaker SkyePharma may reduce the workforce at its production plant in Lyon, France by a third after “long-running” underutilisation of its manufacturing capacity.
Archives for March 9, 2009
Alleged mistreatment of apes provokes anger
An undercover investigation at a primate centre that conducts preclinical research has raised allegations of routine and unlawful mistreatment of the apes and wastage of taxpayers’ money.
PPD doesn’t expect alogliptin milestone this year
PPD says it is unlikely to receive a $25m (€20m) milestone for US approval of Takeda’s diabetes drug alogliptin this year after the FDA said that cardio vascular (CV) safety data filed as part of the NDA are insufficient.
Breaking News
Merck & Co to pay $41bn for Schering Plough
Merck & Co is to buy fellow US drug major Schering Plough for $41bn (€32.6bn) to boost its pipeline in the face of impending patent expiry for key products.
Tigermed aims big with MacroStat alliance
Tigermed is continuing with its plan of partnering to become the top Chinese CRO through an alliance with MacroStat to improve its range of statistical services, further broadening its business.
US approvals provide some respite for Ranbaxy
Two approvals in a week for drugs made at Ranbaxy’s New Jersey OHM Laboratories subsidiary have eased the generics firm’s North American regulatory woes and strengthened its position in the expanding US market.